Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes

Endocrinology

Volumn 150, Issue 12, 2009, Pages 5294-5301

  Kim, Bhumsoo ^a   Backus, Carey ^a   Oh, SangSu ^a   Hayes, John M ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; STREPTOZOCIN DIABETES;

AGE FACTORS; ANIMALS; BLOOD GLUCOSE; BRAIN; CEREBRAL CORTEX; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; SERINE; STREPTOZOCIN; TAU PROTEINS; TIME FACTORS;

EID: 71949112504     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0695     Document Type: Article

References (52)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA 2003 Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60:1119-1122 (Pubitemid 36975801)
2. Stevens MJ, Obrosova I, Pop-Busui R, Greene DA, Feldman EL 2002 Pathogenesis of Diabetic Neuorpathy. In: Porte Jr D, Sherwin RS, Baron A, eds. Ellenberg and Rifkin's diabetes mellitus. Philadelphia: McGraw Hill; 747-770
3. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP 2005 The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726-735 (Pubitemid 40315341)
4. Strachan MW, Deary IJ, Ewing FM, Frier BM 1997 Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438-445
5. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM 1999 Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:1937-1942
6. Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, Grimm KJ, Clarke WL 2005 Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28:71-77 (Pubitemid 40095785)
7. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC 2004 Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474-481 (Pubitemid 38174565)
8. Martins IJ, Hone E, Foster JK, Sünram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN 2006 Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11:721-736 (Pubitemid 44141805)
9. Selkoe DJ 2001 Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766 (Pubitemid 32267077)
10. Johnson GV 2006 Tau phosphorylation and proteolysis: insights and perspectives. J Alzheimers Dis 9:243-250
11. Avila J 2006 Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett 580:2922-2927 (Pubitemid 44250900)
12. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL 2003 Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100:10032-10037
13. Yin H, Kuret J 2006 C-terminal truncation modulates both nucleation and extension phases of tau fibrillization. FEBS Lett 580:211-215 (Pubitemid 43005338)
14. Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M 2006 Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 580:3582-3588 (Pubitemid 43902790)
15. Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS 2006 Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55:3320-3325
16. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A 2007 Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27:13635-13648
17. Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E 2008 Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 86:3265-3274
18. Freude S, Plum L, Schnitker J, Leeser U, Udelhoven M, Krone W, Bruning JC, Schubert M 2005 Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes 54:3343-3348 (Pubitemid 43334322)
19. Sima AA, Zhang W, Xu G, Sugimoto K, Guberski D, Yorek MA 2000 A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. Diabetologia 43:786-793 (Pubitemid 30409154)
20. Li L, Hölscher C 2007 Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56:384-402 (Pubitemid 350166529)
21. Biessels GJ, Kappelle LJ 2005 Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041-1044
22. Sima AAF, Shafrif E 2000 Animal models in diabetes: a primer. Amsterdam: Taylor and Francis
23. Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius 3rd F, Feldman EL 2007 Mouse models of diabetic neuropathy. Neurobiol Dis 28:276-285
24. Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL 2008 Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 30:420-429
25. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL 1999 Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6:347-363 (Pubitemid 29496214)
26. Leventhal PS, Shelden EA, Kim B, Feldman EL 1997 Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance. J Biol Chem 272:5214-5218 (Pubitemid 27090081)
27. Kim B, Oh A, Feldman EL, Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease. Program of the 91st Annual Meeting of The Endocrine Society, Washington, DC, 2009 (Abstract P2-435)
28. Edwards JL, Vincent AM, Cheng HT, Feldman EL 2008 Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1-34
29. Milionis HJ, Florentin M, Giannopoulos S 2008 Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis? CNS Spectr 13:606-613
30. Stephenson J, Fuller JH, Group EICS 1994 Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285 (Pubitemid 24076080)
31. Li ZG, Zhang W, Sima AA 2007 Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817-1824 (Pubitemid 47025451)
32. Chung CW, Song YH, Kim IK, Yoon WJ, Ryu BR, Jo DG, Woo HN, Kwon YK, Kim HH, Gwag BJ, Mook-Jung IH, Jung YK 2001 Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol Dis 8:162-172
33. Hrnkova M, Zilka N, Minichova Z, Koson P, Novak M 2007 Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Res 1130:206-213 (Pubitemid 46053885)
34. Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM 2007 Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci USA 104:10252-10257 (Pubitemid 47175295)
35. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW 2004 Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114:121-130 (Pubitemid 39071651)
36. Mondragón-Rodríguez S, Basurto-Islas G, Santa-Maria I, Mena R, Binder LI, Avila J, Smith MA, Perry G, García-Sierra F 2008 Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. Int J Exp Pathol 89:81-90
37. Delobel P, Lavenir I, Fraser G, Ingram E, Holzer M, Ghetti B, Spillantini MG, Crowther RA, Goedert M 2008 Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am J Pathol 172:123-131 (Pubitemid 351186374)
38. Amadoro G, Corsetti V, Ciotti MT, Florenzano F, Capsoni S, Amato G, Calissano P 21 July 2009 Endogenous Aβ causes cell death via early tau hyperphosphorylation. Neurobiol Aging 10.1016/j.neurobiolaging.2009.06.005
39. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ 1997 Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301-308 (Pubitemid 27082028)
40. Gasparini L, Netzer WJ, Greengard P, Xu H 2002 Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 23:288-293
41. Zhu X, Perry G, Smith MA 2005 Insulin signaling, diabetes mellitus and risk of Alzheimer disease. J Alzheimers Dis 7:81-84 (Pubitemid 40387186)
42. Adlerz L, Holback S, Multhaup G, Iverfeldt K 2007 IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J Biol Chem 282:10203-10209 (Pubitemid 47093446)
43. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I 2002 Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat Med 8:1390-1397 (Pubitemid 36019424)
44. Cheng CM, Tseng V, Wang J, Wang D, Matyakhina L, Bondy CA 2005 Tau is hyperphosphorylated in the insulin-like growth factor-I null brain. Endocrinology 146:5086-5091 (Pubitemid 41653021)
45. Schubert M, Brazil DP, Burks DJ, Kushner JA, Ye J, Flint CL, Farhang-Fallah J, Dikkes P, Warot XM, Rio C, Corfas G, White MF 2003 Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23:7084-7092 (Pubitemid 36975873)
46. Schechter R, Beju D, Miller KE 2005 The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem Biophys Res Commun 334:979-986 (Pubitemid 41074673)
47. de la Monte SM, Wands JR 2005 Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7:45-61 (Pubitemid 40387184)
48. Watson GS, Craft S 2004 Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol 490:97-113 (Pubitemid 38482164)
49. Hong M, Lee VM 1997 Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547-19553 (Pubitemid 27337756)
50. Lesort M, Johnson GV 2000 Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience 99:305-316 (Pubitemid 30628418)
51. Tam J, Rosenberg L, Maysinger D 2004 INGAP peptide improves nerve function and enhances regeneration in streptozotocin-induced diabetic C57BL/6 mice. FASEB J 18:1767-1769 (Pubitemid 39561678)
52. Kellogg AP, Pop-Busui R 2005 Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxid Redox Signal 7:1521-1529 (Pubitemid 41767988)